Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Manulife Financial Corporation (MFC) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

Manulife Financial CorporationTrade
Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

Manulife Financial Corporation vs Zimmer Biomet Holdings Inc — how do they compare? Manulife Financial Corporation trades at $42.51 (market cap $69.96B), while Zimmer Biomet Holdings Inc trades at $90.03 (market cap $17.36B). The key difference: Manulife Financial Corporation is far larger — about 4× Zimmer Biomet Holdings Inc's market cap, and Manulife Financial Corporation pays the higher dividend (3.14%). Which is the better fit depends on your goals.

MFCZBH
Market Cap
$69.96B$17.36B
Sector
FinancialsHealth
52-Week High
$43.39$107.71
52-Week Low
$29.90$79.58
Enterprise Value
$66.52B$24.40B
Dividend Yield
3.14%1.07%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Manulife Financial Corporation

MFC trades at $42.83, down 1.29% today, with a bullish technical signal supported by moving averages. The company reported revenue of $53.01B in 2025 and net income of $5.78B, with a P/E of 17.39. Recent news highlights AI advancements and strong Asia performance, while Q1 2026 earnings missed expectations. Analyst consensus is 57% buy with no sell ratings.

Outlook remains positive driven by AI initiatives and Asia growth, but risks include Q1 earnings miss and regulatory scrutiny. The stock offers steady profitability and dividend income, yet faces headwinds from wealth management outflows and competitive pressures in core markets.

Zimmer Biomet Holdings Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About Manulife Financial Corporation

Manulife provides life insurance and wealth management products and services to individuals and group customers in Canada, the United States, and Asia. Manulife is one of Canada's Big Three Life Insurance companies (the other two are Sun Life and Great West Life). As of Dec. 31, 2021, Manulife reported assets under management or administration of about CAD $1.4 trillion.

Read more on MFC

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Read more on ZBH